May 28, 2004 is a resource of the Oregon Bioscience Association.

 Opinion Poll

Is availability of experienced managers in Oregon constraining your company's growth?

  Yes   No

Please tell us what you think:

(1285) Spectacles invented in Italy using convex lenses for the farsighted.

Oracle Life Sciences User Group Meeting, June 23 - 24, Reston, Virginia

UW BioArray Center: Microarray Data Analysis Workshop, June 21-22 & July 13 - 14, Seattle


Interested in late breaking news? Locate a local seminar or networking meeting? Interested in breaking news? Looking for a local seminar or networking meeting? In our “News” section” you can obtain breaking industry and company news; information about upcoming association, patient and educational related forums, seminars, and events; learn what leading CEO's are reading; and learn about the historical origins of the biotechnology industry in the state. If you want to promote a conference or event, you can obtain information about our unique event advertising services that allow you to cost effectively market your seminars and conferences locally or nationally. If you have a question about our event advertising, and news release posting and archiving services or are aware of an event or resource that we should include, please submit it through the following: Feedback.

Access OBA eNews

Place your event, conference, and seminar ads here...

News Features:

News Resources:

FDA Finalizes New Rule on Donor Eligibility for Human Tissues and Cells

Food and Drug Administration FDA recently published a final rule establishing donor eligibility criteria for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps) to help prevent the transmission of communicable disease when these products are transplanted. This new rule is the second of three proposed rules that have been finalized as part of the Agency's plan to regulate tissues and related products with a comprehensive, risk-based approach. The requirements are comprehensive, yet adequately flexible, and they provide needed protections for patients without imposing unnecessary regulation.

The final rule becomes effective on May 25, 2005. It is accompanied by draft guidance that provides recommendations for complying with the requirements in the donor eligibility rule. Comments on the draft guidance should be received by August 23, 2004.


Print Page

Advanced Technology Construction

Copyright 1996-2004 Info.Resource, Inc., Seattle, WA, USA. 800.709.8907. All rights reserved.
Privacy Policy . Advisory Board . Terms of Use . Advertising is published by Info.Resource in collaboration with the Oregon Bioscience Association.